In the original publication, the names of the BRIVAFIRST group members were incorrectly presented and tagged in the Acknowledgements section. This has now been corrected as follows.
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 10.1007/s40263-021-00856-3) / Lattanzi, S., Canafoglia, L., Canevini, M.P., Casciato, S., Chiesa, V., Dainese, F., De Maria, G., Didato, G., Falcicchio, G., Fanella, M., Ferlazzo, E., Fisco, G., Gangitano, M., Giallonardo, A.T., Giorgi, F.S., La Neve, A., Mecarelli, O., Montalenti, E., Piazza, F., Pulitano, P., et al.. - In: CNS DRUGS. - ISSN 1172-7047. - 35:12(2021), pp. N/A-N/A. [10.1007/s40263-021-00868-z]
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 10.1007/s40263-021-00856-3)
Meletti S.;Rossi J.;
2021
Abstract
In the original publication, the names of the BRIVAFIRST group members were incorrectly presented and tagged in the Acknowledgements section. This has now been corrected as follows.| File | Dimensione | Formato | |
|---|---|---|---|
|
s40263-021-00868-z.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Licenza:
[IR] creative-commons
Dimensione
468.94 kB
Formato
Adobe PDF
|
468.94 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris




